1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Niraparib
Trade Name:
Zejula
Manufacturer/Distributor:
GlaxoSmithKline
Classification:
Antineoplastic agent
ATC Class:
L01XX54 - niraparib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2019/06/27
Date Marketed in Canada (yyyy/mm/dd):
2020/01/09
Presentation:
Capsule: 100 mg. DIN: 02489783
Comments:
For the maintenance treatment of female adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy
Source:
Product monograph
Back to:
Drug Product Listings 
